Savara IncNASDAQ:SVRA
- LAST PRICE1.9100
- TODAY'S CHANGE (%)-0.0600 (-3.0457%)
- Bid / Lots1.9000/ 1
- Ask / Lots2.1400/ 1
- Open / Previous Close1.9700 / 1.9700
- Day Range
- 52 Week Range
- Volume154,676
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | SVRA |
|---|---|---|
| 09:32 ET | 3849 | 1.94 |
| 09:39 ET | 1100 | 1.94 |
| 09:43 ET | 100 | 1.92 |
| 09:50 ET | 100 | 1.925 |
| 09:52 ET | 300 | 1.92 |
| 09:54 ET | 1000 | 1.91 |
| 09:59 ET | 1200 | 1.9 |
| 10:01 ET | 137 | 1.93 |
| 10:08 ET | 1758 | 1.915 |
| 10:10 ET | 600 | 1.92 |
| 10:12 ET | 100 | 1.915 |
| 10:15 ET | 5205 | 1.88 |
| 10:17 ET | 254 | 1.89 |
| 10:21 ET | 700 | 1.9 |
| 10:32 ET | 100 | 1.9 |
| 10:33 ET | 19094 | 1.87 |
| 10:35 ET | 200 | 1.9 |
| 10:42 ET | 303 | 1.89 |
| 10:50 ET | 100 | 1.8968 |
| 10:53 ET | 230 | 1.89 |
| 10:55 ET | 1782 | 1.9 |
| 11:00 ET | 7100 | 1.9002 |
| 11:02 ET | 300 | 1.9092 |
| 11:04 ET | 100 | 1.905 |
| 11:06 ET | 2950 | 1.885 |
| 11:08 ET | 100 | 1.8876 |
| 11:15 ET | 500 | 1.8899 |
| 11:22 ET | 100 | 1.885 |
| 11:24 ET | 500 | 1.88 |
| 11:26 ET | 100 | 1.875 |
| 11:27 ET | 764 | 1.865 |
| 11:31 ET | 131 | 1.8683 |
| 11:33 ET | 336 | 1.86 |
| 11:36 ET | 800 | 1.865 |
| 11:38 ET | 3840 | 1.84 |
| 11:42 ET | 300 | 1.84 |
| 11:44 ET | 236 | 1.83 |
| 11:45 ET | 2304 | 1.86 |
| 11:49 ET | 3919 | 1.86 |
| 11:51 ET | 100 | 1.86 |
| 11:54 ET | 965 | 1.87 |
| 11:56 ET | 10042 | 1.85 |
| 12:00 ET | 200 | 1.85 |
| 12:03 ET | 2164 | 1.86 |
| 12:05 ET | 6776 | 1.86 |
| 12:07 ET | 100 | 1.865 |
| 12:09 ET | 500 | 1.86 |
| 12:12 ET | 600 | 1.86 |
| 12:14 ET | 1111 | 1.86 |
| 12:16 ET | 200 | 1.865 |
| 12:20 ET | 1374 | 1.85 |
| 12:23 ET | 100 | 1.86 |
| 12:25 ET | 200 | 1.86 |
| 12:27 ET | 100 | 1.86 |
| 12:30 ET | 2185 | 1.88 |
| 12:32 ET | 300 | 1.89 |
| 12:34 ET | 100 | 1.89 |
| 12:36 ET | 100 | 1.89 |
| 12:38 ET | 400 | 1.885 |
| 12:39 ET | 200 | 1.89 |
| 12:41 ET | 200 | 1.89 |
| 12:43 ET | 300 | 1.89 |
| 12:48 ET | 100 | 1.885 |
| 12:50 ET | 400 | 1.9 |
| 12:54 ET | 405 | 1.9 |
| 12:56 ET | 100 | 1.905 |
| 12:57 ET | 100 | 1.905 |
| 12:59 ET | 298 | 1.905 |
| 01:01 ET | 100 | 1.905 |
| 01:03 ET | 1700 | 1.89 |
| 01:30 ET | 100 | 1.89 |
| 01:39 ET | 3389 | 1.89 |
| 01:44 ET | 2134 | 1.92 |
| 01:46 ET | 800 | 1.93 |
| 02:00 ET | 200 | 1.94 |
| 02:02 ET | 251 | 1.94 |
| 02:08 ET | 2700 | 1.96 |
| 02:13 ET | 100 | 1.965 |
| 02:15 ET | 2648 | 1.96 |
| 02:18 ET | 295 | 1.95 |
| 02:20 ET | 516 | 1.95 |
| 02:24 ET | 219 | 1.96 |
| 02:26 ET | 100 | 1.97 |
| 02:29 ET | 1400 | 1.98 |
| 02:33 ET | 725 | 1.98 |
| 02:36 ET | 500 | 1.98 |
| 02:38 ET | 1324 | 1.96 |
| 02:42 ET | 300 | 1.945 |
| 02:44 ET | 154 | 1.95 |
| 02:47 ET | 106 | 1.9621 |
| 03:00 ET | 1556 | 1.96 |
| 03:02 ET | 100 | 1.96 |
| 03:03 ET | 700 | 1.96 |
| 03:05 ET | 100 | 1.96 |
| 03:07 ET | 100 | 1.96 |
| 03:09 ET | 300 | 1.96 |
| 03:20 ET | 2335 | 1.97 |
| 03:21 ET | 600 | 1.97 |
| 03:23 ET | 100 | 1.96 |
| 03:30 ET | 145 | 1.96 |
| 03:32 ET | 300 | 1.97 |
| 03:39 ET | 500 | 1.96 |
| 03:41 ET | 1198 | 1.96 |
| 03:43 ET | 100 | 1.96 |
| 03:48 ET | 1200 | 1.93 |
| 03:52 ET | 732 | 1.9 |
| 03:54 ET | 1200 | 1.9 |
| 03:56 ET | 100 | 1.89 |
| 03:57 ET | 1700 | 1.92 |
| 03:59 ET | 5126 | 1.91 |
Mar 10, 2023
BRIEF-Savara Inc Considers Its Exposure Due To Closure Today Of Silicon Valley Bank To Be Immaterial, from 4:41PM ET on Friday Mar 10, 2023 by Thomson Reuters
4:41PM ET on Friday Mar 10, 2023 by Thomson Reuters
Mar 6, 2023
Savara to Present at the Oppenheimer 33rd Annual Healthcare Conference, from 4:05PM ET on Monday Mar 06, 2023 by Business Wire
4:05PM ET on Monday Mar 06, 2023 by Business Wire
Feb 28, 2023
Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4), from 4:05PM ET on Tuesday Feb 28, 2023 by Business Wire
4:05PM ET on Tuesday Feb 28, 2023 by Business Wire
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Savara Inc | 224.7M | -7.2x | --- |
Omeros Corp | 224.9M | -1.2x | --- |
Oric Pharmaceuticals Inc | 224.1M | -2.1x | --- |
Celcuity Inc | 222.3M | -4.2x | --- |
Generation Bio Co | 232.7M | -1.6x | --- |
Immuneering Corp | 231.6M | -5.3x | --- |
Company Information
Savara Inc. is a clinical-stage biopharmaceutical company. The Company is focused on rare respiratory diseases. The Company’s lead program, molgramostim nebulizer solution (molgramostim), a inhaled biologic, is a granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase III development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is an inhaled formulation of recombinant human GM-CSF, is being developed for the treatment of aPAP. Pulmonary alveolar proteinosis (PAP) is a rare lung disease characterized by the build-up of surfactant in the alveoli or air sacs of the lungs.
Contact Information
- Headquarters
- 6836 BEE CAVE ROAD BUILDING 3, SUITE 201AUSTIN, TX, United States 78746
- Phone
- 512-614-1848
- Fax
- 858-552-0876
Executives
- Chairman of the Board, Chief Executive Officer
- Matthew Pauls
- Chief Financial and Administrative Officer
- David Lowrance
- Chief Operating Officer
- Robert Lutz
- Chief Medical Officer
- Raymond Pratt
- Lead Independent Director
- Joseph McCracken
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $224.7M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 114.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.92 |
EPS | $-0.27 |
Book Value | $1.27 |
P/E Ratio | -7.2x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
